Fairvalue-Calculator Fairvalue-Calculator
EN DE

OptiBiotix Health Plc, a life sciences company, (OPTI) Fair Value & Analysis

Healthcare · GB · Market cap 6.5M GBX

Pricep0.0635
Fair Valuep0.0295
Upside-53.5%
Quality95/100
Evidence: Low Range p0.0295 – p0.0295

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

OptiBiotix Health Plc, a life sciences company, (OPTI) currently trades at p0.0635, while our model-based Fair Value estimate is p0.0295 — implying the stock looks roughly 53.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its first-generation products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; and WellBiome a novel in vitro model of the human gut. In addition, the company offers second-generation solutions, including Sweetbiotix which are dietary fibres used as an alternative to sugar and existing sweeteners; and Microbiome Modulators. Further, it provides CholBiome, a food supplement for reducing cholesterol and blood pressure and supporting vascular health; OptiBiotics, a portfolio of prebiotics developed to target…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is OptiBiotix Health Plc, a life sciences company, (OPTI) undervalued?
As of Jun 26, 2026, our model estimates a fair value of p0.0295 versus a price of p0.0635 — about −53% (overvalued). Model-based estimate, not financial advice.
What is the fair value of OPTI?
Our 21-model fair value for OptiBiotix Health Plc, a life sciences company, is p0.0295 (as of Jun 26, 2026), built from audited fundamentals. The current price is p0.0635.
What is the quality score of OPTI?
OptiBiotix Health Plc, a life sciences company, has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.